Arcturus Therapeutics Holdings Inc (ARCT) — Cash Flow Quality Index

Latest as of March 2023: -0.71x

Arcturus Therapeutics Holdings Inc (ARCT) has a Cash Flow Quality Index of -0.71x as of March 2023. Operating cash flow of $-35.87 Million is below net income of $50.75 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Arcturus Therapeutics Holdings Inc (ARCT) cash conversion ratio to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.71x
Operating CF / Net Income

Operating Cash Flow

$-35.87 Million
USD

Net Income

$50.75 Million
USD

Data as of

Mar 2023
Most recent filing

Arcturus Therapeutics Holdings Inc Cash Flow Quality Index (2022–2022)

Historical Cash Flow Quality Index for Arcturus Therapeutics Holdings Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Arcturus Therapeutics Holdings Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Arcturus Therapeutics Holdings Inc (2022–2022)

Year-by-year earnings quality comparison for Arcturus Therapeutics Holdings Inc. For live market cap and the full company financial profile, see Arcturus Therapeutics Holdings Inc market cap and net worth.

Year Quality Index Operating CF (USD) Net Income YoY Change
2022 3.42x $31.99 Million $9.35 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.